1 / 22

Multiple Sclerosis & Treatment of Progression with Interferon-Beta-1a

Multiple Sclerosis & Treatment of Progression with Interferon-Beta-1a . What is Multiple Sclerosis?. Most commonly defined as an autoimmune disease that affects the CNS Characterized by the loss and/or damage of the myelin sheath

hope
Download Presentation

Multiple Sclerosis & Treatment of Progression with Interferon-Beta-1a

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Multiple Sclerosis & Treatment of Progression with Interferon-Beta-1a

  2. What is Multiple Sclerosis? • Most commonly defined as an autoimmune disease that affects the CNS • Characterized by the loss and/or damage of the myelin sheath • Loss of myelin sheath results in the inability of neurons to transmit neural signals properly, causing the many symptoms of MS • Unpredictable and no known cures

  3. Anatomy of the Neuron

  4. Four Major Varieties of MS • Relapsing/remitting (RRMS) • Characterized by periods of flare-ups and remission • Accounts for 85% of MS patients • Primary Progressive (PPMS) • Slow continuous worsening of disease from onset • Only about 10%

  5. Four Major Varieties of MS (cont.) • Secondary Progressive (SPMS) • Initial period of relapsing-remitting, then steady worsening of disease • 50% of patients diagnosed with RRMS develop into this variety within 10 yrs without drug treatment • Progressive Relapsing (PRMS) • Steady worsening with acute relapses • Different from RRMS in that disease progresses during relapses • Only about 5 %

  6. What Causes MS? • Not exactly known • Several theories • Most common—myelin damage results from abnormal response in the immune system • T cells (type of white blood cell) attack myelin • Though to be triggered by environmental and/or genetic factors

  7. Many other theories • MS is pathogen-mediated • Research suggests Chlamydia Pneumoniae and other pathogens may trigger MS • Genetics • Identical twin studies-> one has MS, other has 30% chance • No specific gene/s found yet • Most likely involves a combination

  8. MS Geography • Typical onset between ages 20-50 • Reduces life expectancy by about 10-15 yrs • About ½ patients survive 30+ yrs from onset • Affects 2-3 times as many women than men • Research suggests that genetic factors play a role • More common among people of European descent • About 400,000 Americans have MS

  9. Symptoms of MS • Wide variety due to nature of disease • Different classifications of symptoms • Visual • Motor • Sensory • Cognitive • Coordination/Balance • Bowel, Bladder, and Sexual • Others

  10. Diagnosis of MS • No single test for diagnosing MS • Usually diagnosed when all other possibilities ruled out • Many tests • Medical history • Nervous system functioning • MRI, Evoked potential tests, spinal tap

  11. Basic “Rule” for Diagnosis • Est. by committee sponsored by NMSS in 1965 • Must have BOTH of the following: • Evidence of myelin loss in at least 2 areas occurring in different places at different times • Any other diseases that could account for the above have been ruled out • Revised in 1983 by Poser to take into account advances in MRI technology

  12. Treatments for MS • No known cure • Treatments involve relieving the symptoms or slowing the progression of the disease • These are mostly drug treatments • Also CAM’s- Complementary and Alternative Medicine

  13. CAM’s • Used with or instead of conventional drug treatments • Some include • Acupuncture • Herbal medicine • Yoga • Relaxation techniques • Hypnosis

  14. Conventional Drug Treatments • Disease-modifying drugs* • ABC Treatments • Chemotherapeutic Agents • Corticosteroids & ACTH • Drugs that help with symptoms • Wide variety from anti-depressants (depression) to laxatives (bowel dysfunction) to anti-convulsants (pain/altered sensations)

  15. ABC Treatments • Most popular drug treatments for modifying course of disease • Work by regulating aspects of the immune system • ABC refers to the 3 major brand names of this category of drugs: Avonex, Betaseron/Betaferon, and Copaxone • Also now added Rebif and Novantrone

  16. ABC Treatments Cont. • Interferon beta-1a • Avonex, Rebif • Interferon beta-1b • Betaseron/Betaferon • Glatiramer acetate • Copaxone • Mitoxantrone • Novantrone

  17. What are Interferons? • Occur naturally in human body • Proteins that prevent viral multiplication by stimulating the production of antiviral proteins in normal cells • Interferon-alpha, Interferon-beta, and Intereron-gamma

  18. Avonex • Interferon-beta-1a • Used for RRMS and SPMS w/relapses • Produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced • The resulting amino acid sequence is identical to human interferon-beta

  19. Avonex • Mechanisms by which it exerts it effects not fully understood • Pharmacokinetics in MS patients not evaluated • Recommended dosage of 30 mcg to be injected intramuscularly one weekly • Not recommended subcutaneously- adverse reactions mainly at site of injection* • No known interactions with other drugs • Safety of doses above 60 mcg has not been evaluated-> do not know lethal dose

  20. Current Avonex Research • Avonex fairly new • Lots of research being done, few consistent findings yet • Most research with Avonex focuses on: • Comparison with other drugs of its type • Testing properties of the drug by altering dosages,etc. • Seeing how well drug modifies disease course in placebo studies

  21. Future Research on MS • Finding the cause • Stopping/slowing progress of disease • Repairing damage already done • Remyelination • Better ways of treating symptoms • Focusing on the social implications

  22. Recommended Websites to Learn More • http://www.avonex.com • http://www.nationalmssociety.org

More Related